Single User PDF
GBP 1699.00  

PDF Departmental License
GBP 2999.00  

PDF Site License
GBP 4999.00  

PDF Global Site License
GBP 6999.00  

UK Head Office
+44(0)1494 771734
or Buy Now! online

Hot Reports:
Brazil Healthcare - New Opportunities for Growth


US Non-Invasive Prenatal Diagnostics - Market Insight


Global Genetic Testing Market Forecast to 2015


US Clinical Laboratory Testing Market Assessment


US Cardiac Device Market Analysis


Pharma Leader Series: Top 20 Antibacterial Drug Manufacturers 2012-2022


In Vitro Diagnostics: World Market Outlook 2012-2022


Pharma Wholesale and Distribution Market: World Outlook 2012-2022

Table of Contents

Management Report
Published: February 2012
Pages: 174
Tables: For full details, please email deborahf@cmsinfo.com
From: GBP 1699.00  Buy Now!
Research from: pharmaceuticalmarketresearch
Sector: Prescription Medicines

Cancer treatments - discover which products have greatest potential

Where are cancer-treating drugs heading? Visiongain's report shows you potential revenues to 2022, with data, forecasts and discussions.

This study investigates leading drugs to treat human cancers. It lets you assess potential sales trends at world market, therapeutic submarket, product and national level to 2022.

How will 25 leading products - including Avastin, Rituxan, Herceptin and Glivec/Gleevec - perform from 2012? See potential revenues and other information. The study also assesses eight recently approved drugs.

Our investigation gives you business research and analysis with sales forecasts. You also see forecasting of five submarkets to 2022, finding potential revenues:
• Traditional antineoplastic agents
• Novel antineoplastic agents
• Hormone therapies
• Immunotherapies
• Other agents.

Find coverage of oncology R&D too, assessing trends and outlooks there.

What does the future hold? The pharma industry has great potential for improving products and increasing revenues from cancer treatments. R&D pipelines in oncology are strong.

There are many promising developments in biopharma, including antibody-drug conjugates and bispecific monoclonal antibodies. The therapeutic and commercial importance of anti-cancer agents will increase from 2012 to 2022, our analysis finds.

What about leading companies? Our work discusses Roche, Novartis, AstraZeneca, Eli Lilly, Celgene and other pharmaceutical companies, evaluating prospects of the industry and market.

Commercial opportunities for cancer treatment remain, with high revenues likely from many drugs - small-molecule products and biological agents (biologicals) - to 2022.

You can investigate the future of cancer treatment now, discovering potential revenues and other trends. Our report shows and explains.

Revenue forecasts, market shares, developmental trends and discussions

In visiongain's report you find revenue forecasting, growth rates and market shares. Also, you see qualitative analyses (SWOT and STEP) and discussion of R&D activities. You receive 146 tables and charts and three research interviews.

Nine ways Leading Anti-Cancer Drugs and Associated Market 2012-2022 helps you

In particular, the study gives you the following knowledge on the topic:
• Find potential revenues to 2022 for the world market and submarkets
• Discover revenue forecasts to 2022 for 26 prominent drugs
• View prospects for emerging products, seeing their potential
• See market forecasting to 2022 for the US, Japan, the UK, Germany, France, Spain, Italy (EU5), Brazil, Russia, India and China (BRIC)
• Assess leading companies, discovering activities and outlooks
• Review R&D for a range of applications, seeing pipeline trends
• Investigate competition and opportunities influencing sales
• Find out what will stimulate and restrain the industry and market
• View opinions from our survey, receiving detailed interviews.

There, you find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains.

We keep you informed about commercial trends and prospects, helping you to stay ahead.

Gain business research and analysis now for cancer treatments

Our study is for everybody needing industry and market analyses for anti-cancer drugs. You find data, trends and answers there. Please order that report now.

Top of Page